DRUG
Bright Minds Biosciences Inc
NASDAQ: DRUG · HEALTHCARE · BIOTECHNOLOGY
$89.11
+0.13% today
Updated 2026-04-29
Market cap
$872.62M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.02
Dividend yield
—
52W range
$23 – $124
Volume
0.2M
Bright Minds Biosciences Inc (DRUG) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-27.00%
ROA
-15.70%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | — | $-236151.00 | — | — | — |
| 2020 | $0.00 | $-485945.00 | — | — | — |
| 2021 | $0.00 | $-8.52M | — | — | — |
| 2022 | $0.00 | $-14.96M | — | — | — |
| 2023 | $0.00 | $-7.37M | — | — | — |
| 2024 | $0.00 | $-2.80M | — | — | — |
| 2025 | $0.00 | $-12.23M | — | — | — |